Validate Smart Breath Analyzer as Screening Tool for Diabetic, Hepatic, Renal, Lung, and Other Metabolic Disorders | MicrobiomeTrials← Back to trialsNCT07646015
Validate Smart Breath Analyzer as Screening Tool for Diabetic, Hepatic, Renal, Lung, and Other Metabolic Disorders
CompletedOBSERVATIONAL
Trial Details
Start: 2022-10-03Est. Completion: 2023-10-03
Enrollment target: 3,000 participants Locations- Dept. of Community Medicine, JSS Medical College, Mysore, Karnataka, India
Other microbiome trials you might be interested in
T2DM (Type 2 Diabetes Mellitus)
The goal of this clinical trial is to evaluate whether an evidence-based anti-inflammatory dietary intervention can redu…
Hefei, ChinaEst. completion Nov 2026
Type 2 Diabetes
This study aims to investigate how fat accumulation in the pancreas contributes to the development of type 2 diabetes (T…
Edinburgh, United KingdomEst. completion Mar 30, 2029
Obesity
Diet Therapy
Diabetes Type 2
Background:
\- LIFE-Moms (Lifestyle Interventions for Expectant Moms) is a national project that is studying pregnant w…
Phoenix, United StatesCompleted Mar 27, 2017